SYSCHEM (INDIA)
Back to Balance Sheet
|
SYSCHEM (INDIA) Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹1.53 Cr | ₹9.35 Cr | ₹25 Cr | ₹23 Cr | ₹26 Cr |
What is the latest Total Non-Current Liabilities ratio of SYSCHEM (INDIA) ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹1.53 Cr |
| Mar2024 | ₹9.35 Cr |
| Mar2023 | ₹25 Cr |
| Mar2022 | ₹23 Cr |
| Mar2021 | ₹26 Cr |
How is Total Non-Current Liabilities of SYSCHEM (INDIA) Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.53 Cr | -83.70 | |
| Mar2024 | ₹9.35 Cr | -62.79 | |
| Mar2023 | ₹25 Cr | 7.46 | |
| Mar2022 | ₹23 Cr | -8.93 | |
| Mar2021 | ₹26 Cr | - | |
Compare Total Non-Current Liabilities of peers of SYSCHEM (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYSCHEM (INDIA) | ₹200.8 Cr | -6.7% | -4.4% | -5.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
SYSCHEM (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYSCHEM (INDIA) | -6.7% |
-4.4% |
-5.1% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses